StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.71+0.08 (+12.14%)

Close on Nov 18, 2026Market cap $5.36MP/E –Yield –

Cerenome operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Cerenome's operating cash flow for the twelve months ending Jun 30, 2026 was -$22.18M. For fiscal 2025 it was -$20.78M. The highest annual figure on record is -$5.91M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$20.78M–
FY2024Dec 31, 2024-$10.55M–
FY2023Dec 31, 2023-$12.85M–
FY2022Dec 31, 2022-$12.97M–
FY2021Dec 31, 2021-$10.28M–
FY2020Dec 31, 2020-$8.43M–
FY2019Dec 31, 2019-$5.91M–
FY2018Dec 31, 2018-$11.98M–
FY2017Dec 31, 2017-$18.13M–
FY2016Dec 31, 2016-$19.53M–
FY2015Dec 31, 2015-$20.47M–
FY2014Dec 31, 2014-$30.33M–
FY2013Dec 31, 2013-$34.56M–
FY2012Dec 31, 2012-$32.19M–
FY2011Dec 31, 2011-$35.32M–
FY2010Dec 31, 2010-$23.57M–
FY2009Dec 31, 2009-$23.81M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$7.13M–
Q1 FY2026Mar 31, 2026-$6.24M–
Q4 FY2025Dec 31, 2025-$6.26M–
Q3 FY2025Sep 30, 2025-$2.55M–
Q2 FY2025Jun 30, 2025-$5.80M–
Q1 FY2025Mar 31, 2025-$6.17M–
Q4 FY2024Dec 31, 2024-$1.21M–
Q3 FY2024Sep 30, 2024-$3.68M–
Q2 FY2024Jun 30, 2024-$1.15M–
Q1 FY2024Mar 31, 2024-$4.51M–
Q4 FY2023Dec 31, 2023-$1.88M–
Q3 FY2023Sep 30, 2023-$2.40M–
Q2 FY2023Jun 30, 2023-$2.78M–
Q1 FY2023Mar 31, 2023-$5.79M–
Q4 FY2022Dec 31, 2022-$2.23M–
Q3 FY2022Sep 30, 2022-$4.22M–
Q2 FY2022Jun 30, 2022-$2.64M–
Q1 FY2022Mar 31, 2022-$3.88M–
Q4 FY2021Dec 31, 2021-$2.62M–
Q3 FY2021Sep 30, 2021-$2.25M–
Q2 FY2021Jun 30, 2021-$2.40M–
Q1 FY2021Mar 31, 2021-$3.01M–
Q4 FY2020Dec 31, 2020-$3.22M-411.2%
Q3 FY2020Sep 30, 2020-$2.30M–
Q2 FY2020Jun 30, 2020-$1.41M–
Q1 FY2020Mar 31, 2020-$1.50M–
Q4 FY2019Dec 31, 2019$1.04M–
Q3 FY2019Sep 30, 2019-$2.52M–
Q2 FY2019Jun 30, 2019-$1.15M–
Q1 FY2019Mar 31, 2019-$3.27M–
Q4 FY2018Dec 31, 2018-$2.49M–
Q1 FY2018Mar 31, 2018-$4.12M–
Q4 FY2017Dec 31, 2017-$4.22M–
Q3 FY2017Sep 30, 2017-$4.05M–
Q2 FY2017Jun 30, 2017-$5.03M–
Q1 FY2017Mar 31, 2017-$4.83M–
Q4 FY2016Dec 31, 2016-$4.16M–
Q3 FY2016Sep 30, 2016-$4.64M–
Q2 FY2016Jun 30, 2016-$5.68M–

More Cerenome figures

See a number that looks wrong?